Rabbit Cuterebriasis Study Guide

Overview and Clinical Importance

Cuterebriasis is a parasitic infestation caused by larvae of Cuterebra species (bot flies, order Diptera, family Cuterebridae). While rabbits and rodents are the natural hosts for these obligate parasites, domestic pet rabbits represent atypical hosts that can develop severe, potentially life-threatening disease due to aberrant larval migration. Understanding this multisystemic parasitosis is critical for NAVLE examination as it presents diagnostic challenges and requires prompt recognition to prevent fatal complications.

Parasite Biology and Taxonomy

Taxonomy

The genus Cuterebra contains more than 70 species restricted to the Western Hemisphere (North and South America). Two important subgenera affect lagomorphs:

• Subgenus Trypoderma: 22 species that primarily parasitize rabbits and hares (lagomorphs)
• Subgenus Cuterebra: 12 species that parasitize rodents

The most clinically relevant species for domestic rabbits is Cuterebra buccata, though other lagomorph-infesting species may be involved depending on geographic location.

Life Cycle

Understanding the complete life cycle is essential for both diagnosis and prevention:

Epidemiology and Host Factors

Geographic Distribution

Cuterebriasis is most commonly reported in the eastern United States and southeastern Canada (particularly Ontario), with highest incidence in the Midwest and Northeast regions. Cases occur throughout North America where rabbit and rodent populations exist.

Seasonal Pattern

Peak Season: Late summer through early fall (July-October). This corresponds to larval maturation and warble formation. Clinical cases presenting outside this timeframe should prompt consideration of other differentials.

Host Susceptibility

Natural Hosts: Wild rabbits (cottontails, jackrabbits) and hares. Infection prevalence may reach 30-70 percent in wild populations in endemic areas. Natural hosts typically show minimal clinical signs.

Atypical Hosts: Domestic rabbits (Oryctolagus cuniculus), dogs, cats, ferrets, and rarely humans. Atypical hosts experience more severe disease with higher risk of aberrant migration and fatal complications.

Risk Factors for Domestic Rabbits

• Outdoor housing or access to outdoor environments
• Proximity to wild rabbit or rodent burrows
• Geographic location in endemic areas
• Summer/fall season

Exam Focus: For NAVLE, remember that any outdoor rabbit presenting with neurological signs, respiratory distress, or ocular disease during July-October should have cuterebriasis on the differential list, even without visible subcutaneous lesions. Aberrant migration can occur without obvious warbles!

Clinical Presentations

Cuterebriasis in domestic rabbits presents in two major forms: cutaneous (typical) and systemic (aberrant migration). The multisystemic nature makes this a high-yield NAVLE topic.

Cutaneous Form (Typical Presentation)

Clinical Signs

• Subcutaneous swelling (warble) approximately 1 cm diameter
• Most common locations: head, neck, periocular region, dorsum
• Breathing pore (fistula) with well-defined margins (2-4 mm diameter)
• Serous to serosanguineous discharge from pore
• Matted hair around lesion
• Variable pain (increased if secondary bacterial infection present)
• Fluctuant mass on palpation

Differential Diagnoses: Subcutaneous abscess (most common), foreign body granuloma, neoplasia, hematoma, other parasitic cysts. The presence of a central breathing pore with well-defined margins is pathognomonic for cuterebriasis and helps differentiate from abscesses which typically have irregular, inflamed margins.

Aberrant Migration Forms (Atypical Presentations)

In atypical hosts like domestic rabbits, larvae may migrate to ectopic sites, causing severe multisystemic disease:

Ophthalmomyiasis

Externa: Larva in conjunctiva or periocular tissues

Clinical signs: Marked periocular swelling, blepharospasm, chemosis, mucopurulent to serous ocular discharge, visible puncture wound on eyelid, anorexia, lethargy

Interna: Larva within globe (anterior or posterior chamber) - rare but severe

Clinical signs: Exudative uveitis, blindness, secondary glaucoma

Neurological Cuterebriasis

Larval migration through CNS via cribriform plate, middle ear, or other foramina. This is the most severe and potentially fatal form.

Clinical Signs:

• Acute onset pelvic limb paresis or paralysis (often asymmetric)
• Ataxia, circling, head tilt (vestibular signs)
• Seizures, altered mentation, depression
• Blindness (cortical or focal)
• Abnormal behavior, lethargy
• Lumbar spinal pain on palpation
• CRITICAL: History of violent sneezing or upper respiratory signs 1-2 weeks prior to neurological signs

Pathogenesis: Larvae gain CNS access through nasal cavity → cribriform plate. Migration causes hemorrhage, necrosis, eosinophilic inflammation, and potential vascular compromise leading to ischemic changes.

Respiratory Cuterebriasis

Migration through trachea, pharynx, larynx, diaphragm, or pulmonary tissues.

Clinical Signs:

• Dyspnea, respiratory distress
• Nasal discharge (unilateral or bilateral)
• Sneezing, coughing
• Nasal/facial swelling
• Open-mouth breathing (rabbits are obligate nasal breathers)

Systemic Manifestations

• Anorexia and decreased appetite (common with any form)
• Abnormal body temperature (hyperthermia or hypothermia)
• Secondary bacterial infections at larval sites
• Rarely: DIC, SIRS (more common in small breed dogs, but possible in rabbits)

Diagnosis

Cutaneous Form

Definitive Diagnosis: Visual identification of the larva through the breathing pore or after surgical extraction. The presence of a third-instar larva (dark, heavily spined, 3-4.5 cm) in a subcutaneous cyst with a breathing pore is pathognomonic.

Physical Examination:

• Palpate for fluctuant subcutaneous mass
• Identify central breathing pore (2-4 mm with well-defined margins)
• Visualize larva's posterior spiracles through pore (dark, spine-covered structure)
• Gentle probing with forceps may reveal larva movement

Larval Identification:

• Second instar: 5-15 mm, gray to white/cream
• Third instar: 3-4.5 cm, dark brown/black, thick body with prominent black spicules
• Species-level identification often impossible without rearing to adult

Aberrant Migration Forms

Clinical Pathology

Complete Blood Count:

• Peripheral eosinophilia may be present but is NOT consistent
• Leukocytosis with left shift (if secondary infection present)
• Normal CBC does NOT rule out cuterebriasis

Cerebrospinal Fluid Analysis:

• Often normal or shows minimal inflammation
• May show increased protein and/or pleocytosis
• Eosinophilic inflammation if present supports diagnosis but is inconsistent

Diagnostic Imaging

Histopathology

Post-mortem findings (if euthanasia or death occurs): Hemorrhage, necrosis, and eosinophilic inflammation surrounding larval migration tracks. Vascular compromise and ischemic changes in affected tissues. Toxic factors elaborated by larvae contribute to tissue damage.

Treatment

Cutaneous Form - Surgical Removal

Removal Technique

• Sedation/Anesthesia: Recommended for patient comfort and to prevent crushing of larva
• Enlarge breathing pore: Carefully use sterile mosquito forceps or small scissors to gently enlarge the opening
• Optional - Petroleum jelly technique: Cover breathing pore with white petroleum jelly for 10-15 minutes. This occludes airflow and may cause larva to emerge or move toward opening, facilitating removal
• Extract larva INTACT: Grasp larva firmly with mosquito forceps. Apply steady, gentle traction. Remove as one complete piece - rupture can cause:

• Type I hypersensitivity reaction / anaphylaxis (rare but reported)

• Chronic foreign body reaction

• Recurrent abscess formation

• DO NOT SQUEEZE: Never compress or squeeze the warble - this will rupture the larva

Post-Removal Wound Care

• Thorough flush: Copious sterile saline irrigation of the cyst cavity
• Debridement: Remove necrotic tissue if present
• Healing: Allow to heal by secondary intention (granulation). DO NOT suture closed
• Timeline: Healing may take weeks to months due to size of cavity

Medical Therapy

Aberrant Migration - CNS and Respiratory

CRITICAL: Treatment of systemic cuterebriasis is controversial and carries guarded prognosis. Surgical removal of larvae from CNS or deep tissues may not be feasible.

Prognosis

Factors Affecting Prognosis:

• Early diagnosis and intervention: Critical for aberrant cases
• Location of larvae: Superficial better than deep
• Number of larvae: Single better than multiple
• Extent of tissue damage: Less inflammation = better outcome
• Intact larval removal vs rupture
• Secondary complications (infection, anaphylaxis, ischemia)

Prevention

Primary Prevention Strategies:

• Indoor Housing: Most effective prevention - keep pet rabbits indoors during peak bot fly season (July-October)
• Protective Screening: If outdoor housing necessary, install fine mesh screens over enclosures during fly season
• Avoid High-Risk Areas: Keep rabbits away from wild rabbit burrows, rodent dens, and known infestation sites
• Environmental Management: Control wild rabbit/rodent populations near rabbit housing
• Regular Inspection: Weekly examination of outdoor rabbits during peak season for early warble detection

Prophylactic Antiparasitics:

• Topical Products: Fipronil, imidacloprid, or selamectin may provide some protection but efficacy not well established for rabbits
• Systemic Macrocyclic Lactones: Ivermectin or moxidectin may kill migrating larvae but no products are labeled for Cuterebra prevention in rabbits
• NOTE: No FDA-approved products exist specifically for Cuterebra prevention in any species. All use is extralabel.

Memory Aid Mnemonics

CUTEREBRA = Key Clinical Features

CNS migration = Violent sneezing BEFORE neuro signs

Under skin = Subcutaneous warbles (most common)

Temporal pattern = July to October peak

Entry via orifices = Mouth/nose (NOT skin penetration)

Rabbits and Rodents = Natural hosts

Eosinophilia = Inconsistent finding

Breathing pore = Diagnostic for cutaneous form

Removal intact = Critical (do NOT rupture)

Atypical hosts = Pet rabbits (worse prognosis than wild)

Treatment Protocol = STEROIDS FIRST

Steroids BEFORE ivermectin (1-2 hours prior)

Time for dexamethasone to work

Evade death-related inflammation

Reduce CNS damage

Only THEN give ivermectin

Ivermectin kills larvae

Death of larvae = more inflammation (prevented by steroids)

Supportive care essential throughout